Latigo Bio Overview
- Year Founded
-
2018
- Status
-
Public
- Employees
-
59
- Stock Symbol
-
LTGO
- Share Price
-
$12.93
- (As of Thursday Closing)
Latigo Bio General Information
Description
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
Contact Information
Website
www.latigobio.comCorporate Office
- 1300 Rancho Conejo Boulevard
- Suite 305
- Thousand Oaks, CA 91320
- United States
Corporate Office
- 1300 Rancho Conejo Boulevard
- Suite 305
- Thousand Oaks, CA 91320
- United States
Latigo Bio Timeline
Latigo Bio Stock Performance
As of 12-Nov-2026, Latigo Bio’s stock price is $12.93. Its current market cap is $857M with 66.3M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $12.93 | $13.52 | $10.24 - $25.93 | $857M | 66.3M | 294K | -$6.07 |
Latigo Bio Financials Summary
As of 30-Sep-2026, Latigo Bio has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 |
|---|---|---|---|
| EV | 1,372,028 | ||
| Revenue | 0 | 0 | 0 |
| EBITDA | (109,834) | (111,861) | (63,203) |
| Net Income | (107,291) | (109,167) | (61,183) |
| Total Assets | 408,456 | 75,516 | 22,864 |
| Total Debt | 1,188 | 690 | 851 |
Latigo Bio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Latigo Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Latigo Bio Comparisons
Industry
Financing
Details
Latigo Bio Competitors (4)
One of Latigo Bio’s 4 competitors is Centrexion Therapeutics, a Venture Capital-Backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Centrexion Therapeutics | Venture Capital-Backed | Boston, MA | ||||
| Vertex Pharmaceuticals | Formerly VC-backed | Boston, MA | ||||
| Arcturus Therapeutics Holdings | Formerly VC-backed | San Diego, CA | ||||
| Forum Markets | Corporation | Palm Beach, FL |
Latigo Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Latigo Bio Patents
Latigo Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026169890-A1 | Sodium channel blocking compounds, derivatives thereof, and methods of their use | Pending | 06-Feb-2025 | ||
| WO-2026122558-A1 | Sodium channel blocking compounds, derivatives thereof, and methods of their use | Pending | 03-Dec-2024 | ||
| WO-2025264645-A1 | Sodium channel blocking compounds, derivatives thereof, and methods of their use | Pending | 18-Jun-2024 | ||
| AU-2024315080-A1 | Sodium channel blocking compounds, derivatives thereof, and methods of their use | Pending | 01-Aug-2023 | ||
| EP-4753699-A1 | Sodium channel blocking compounds, derivatives thereof, and methods of their use | Pending | 01-Aug-2023 | C07D211/38 |
Latigo Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Latigo Bio Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Latigo Bio FAQs
-
When was Latigo Bio founded?
Latigo Bio was founded in 2018.
-
Where is Latigo Bio headquartered?
Latigo Bio is headquartered in Thousand Oaks, CA.
-
What is the size of Latigo Bio?
Latigo Bio has 59 total employees.
-
What industry is Latigo Bio in?
Latigo Bio’s primary industry is Biotechnology.
-
Is Latigo Bio a private or public company?
Latigo Bio is a Public company.
-
What is Latigo Bio’s stock symbol?
The ticker symbol for Latigo Bio is LTGO.
-
What is the current stock price of Latigo Bio?
As of 12-Nov-2026 the stock price of Latigo Bio is $12.93.
-
What is the current market cap of Latigo Bio?
The current market capitalization of Latigo Bio is $857M.
-
Who are Latigo Bio’s competitors?
Centrexion Therapeutics, Vertex Pharmaceuticals, Arcturus Therapeutics Holdings, and Forum Markets are competitors of Latigo Bio.
-
What is Latigo Bio’s annual earnings per share (EPS)?
Latigo Bio’s EPS for 12 months was -$6.07.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
